BCS Private Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BCS Private Wealth Management's AMGN Position: Q2 2026 in Review
BCS Private Wealth Management reduced its Amgen (AMGN) stake by 17% in Q2 2026, selling an estimated $325K and leaving 4,800 shares worth $1.74M. The position accounts for 0.52% of the portfolio, ranked #49.
BCS Private Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.02M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- BCS Private Wealth Management held 4,800 shares of Amgen worth $1.74M as of Q2 2026.
- BCS Private Wealth Management sold 950 Amgen shares in Q2 2026, an estimated $325K.
- Amgen made up 0.52% of BCS Private Wealth Management's portfolio in Q2 2026, its #49 holding.
- BCS Private Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
- BCS Private Wealth Management's Amgen position peaked at $2.02M in Q1 2026.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.